Status:
RECRUITING
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Collaborating Sponsors:
521 Hospital of NORINCO Group
Shaanxi Provincial People's Hospital
Conditions:
Infective Endocarditis
Eligibility:
All Genders
18+ years
Brief Summary
In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used mult...
Detailed Description
Infective endocarditis is an inflammation of the inner lining of the heart valves or ventricular walls caused by direct infection of the heart by bacteria, fungi and other microorganisms via the blood...
Eligibility Criteria
Inclusion
- Patients with clinically confirmed infective endocarditis
Exclusion
- Patients refuse to sign informed consent form
- Patients who combined with serious systemic diseases, cannot tolerate the acquisition of biological samples
Key Trial Info
Start Date :
May 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05965362
Start Date
May 9 2024
End Date
December 31 2028
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Xian Jiantong University
Xi'an, Shaanxi, China, 710061